SEC Form 4 · accession 0001127602-18-006441
Bioverativ Inc. · BIVV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Greene
Officer — EVP, CFO and Treasurer
Period of report
Feb 14, 2018
Accepted (ET)
Feb 15, 2018 · 5:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001681689
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 14, 2018 | M | 7,114 | $0.00 | A | 7,614 | D | |
| Common StockF2 | Feb 14, 2018 | F | 2,118 | $103.52 | D | 5,496 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF3,F4 | — | Feb 14, 2018 | M | 7,114 | D | — | — | Common Stock | 7,114 | 14,230 | D |
Explanation of responses
- F1Includes an aggregate of 500.0568 shares acquired under the Company's Employee Stock Purchase Plan on April 5, 2017 and July 6, 2017.
- F2Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock units.
- F3Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- F4The restricted stock units vest in three equal annual installments beginning on February 14, 2018.